Skip to main content
IMRX logo

IMRX · Immuneering Corp

Track IMRX — free
$5.21 +0.15 (+2.96%)
Market Cap
$327.37M
Shares
64.70M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Benjamin Zeskind $1,660,612
Brett Hall $1,289,504
Michael D. Bookman $890,362
Fiscal 2024
Executive Total
Benjamin Zeskind $1,945,092
Brett Hall $1,425,506
Michael D. Bookman $1,088,351
Fiscal 2023
Executive Total
Benjamin Zeskind $1,918,201
Brett Hall $1,399,319
Fiscal 2022
Executive Total
Benjamin Zeskind $2,054,966
Brett Hall $1,355,116
Scott Barrett $1,078,022
Fiscal 2021
Executive Total
Biren Amin $3,273,530
Benjamin Zeskind $1,891,806
Brett Hall $1,871,725
Fiscal 2020
Executive Total
Benjamin Zeskind $806,045
Brett Hall $775,200
Biren Amin

Executive changes

Person Change Filed
Andrew Gengos Appointed 2026-06-15
Thomas J. Schall, Ph.D. Appointed 2024-03-14
Mallory Morales Appointed 2023-06-14
Biren Amin Resigned 2022-07-25
Diana F. Hausman Appointed 2022-01-18
Key facts CIK 1790340 CUSIP 45254E107 13F (30d) 107 filings 106 filers Visit website Investor relations